CEO Donald Macpherson emphasized the company's strong financial performance in 2024, highlighting over $17.2 billion in sales, a 4.2% increase, and adjusted EPS growth of over 6% to $38.96. He stated ...

FY2024 guidance has been revised upward, with revenue growth of 11% projected across the three primary segments. Adjusted EBITA for FY2024 is expected to rise year-over-year, driven by strong ...

AbbVie reported strong Q4 results, driven by Skyrizi, Rinvoq, neuroscience products, and eye care. Click here to find out why ...

Learn about TSMC's stock slump despite strong results, driven by increased AI chip demand and undervaluation compared to ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Veren Inc. plans to generate C$3.8 billion in cash flow and is focusing on growth and returning capital to shareholders.

Visa Inc. is a promising investment opportunity with strong financial performance, growth outlook, and potential. Click for ...

B2Gold is a high-risk, high-reward investment in the gold mining sector, with potential for significant growth by 2025. Click ...

Viavi Solutions Inc. post-earnings release showcases growth in core networking and challenges in some segments. Click for my ...

Apple's iPhone revenue struggles in China and wearables show softness, but potential improvements in AI and the upcoming ...

Discover how XPEL has achieved impressive revenue growth and stability, and know more about its future expansion plans in the ...